About Biscayne Pharma
Biscayne Pharma is a company based in Miami (United States) founded in 2012 was acquired by Supernus Pharmaceuticals in September 2018. Biscayne Pharma has raised $10.53 million across 5 funding rounds from investors including Supernus Pharmaceuticals, GF Securities and Quark Venture. Biscayne Pharma offers products and services including Health Blogs and Supplements Information.
- Headquarter Miami, United States
- SectorsHealthcare
- Website biscaynepharma.com
- Social LinkedIn
- Acquired by Supernus Pharmaceuticals (Sep 2018)
- Total Equity Funding$10.53M (USD)
in 5 rounds
- Latest Funding Round$3M (USD), Series B
Jan 2017
- InvestorsSupernus Pharmaceuticals
& 4 more
- Acquired bySupernus Pharmaceuticals
(Sep 2018)
Products & Services of Biscayne Pharma
Biscayne Pharma offers a comprehensive portfolio of products and services, including Health Blogs and Supplements Information.
Delivers articles on wellness, meditation, and health tips.
Provides details on supplements like CBD oil and pain relief options.
Funding Insights of Biscayne Pharma
Biscayne Pharma has successfully raised a total of $10.53M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $3 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.53M
- Total Rounds 5
- Last Round Series B — $3M
- First Round $1.5M
(Jan 2013)
- Investors Count 4
All 5 funding rounds of Biscayne Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | $3M | Series B | – | – | |
| Nov 2015 | $609,000 | Debt – Conventional | – | – | – |
| Jan 2015 | $3.4M | Series A | – | – | |
| May 2014 | $2.63M | Series A | – | – | – |
| Jan 2013 | $1.5M | Seed | – | – | – |
5 investors in total: 5 institutional.
Investors in Biscayne Pharma
Biscayne Pharma has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Supernus Pharmaceuticals, GF Securities and Quark Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life Sciences focused early stage VC firm investing in North America | – | quarkventure.com | Vancouver, Canada | |
- | – | mesaverdevp.com | - | |
Provider of investment & asset management and financial services | 1991 | gf.com.cn | Guangzhou, China | |
Support is provided for Florida's technology ventures and innovation. | – | florida-institute.com | Clearwater, United States | |
Specialty pharmaceutical products for CNS diseases are developed and commercialized. | 2005 | supernus.com | Rockville, United States |
Investor details for Biscayne Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Biscayne Pharma
4 dated milestones of Biscayne Pharma across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Biscayne Pharma is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series B, of $3.0M.
- Exit Acquired by Supernus Pharmaceuticals.
Latest news on Biscayne Pharma
Complete news archive for Biscayne Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Biscayne Pharma
10 companies that operate in the same segment as Biscayne Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biscayne Pharma
Biscayne Pharma was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Biscayne Pharma is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Biscayne Pharma is a funded company, having raised a total of $10.53M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Jan 2013.
Biscayne Pharmaceuticals is a clinical stage drug development biotech focusing on CNS disorders (refractory epilepsy) and drug-resistant cancer. Biscayne acquired the CNS program, and the molecule BIS-001, as part of its merger with Insero Health in 2015. BIS-001, which has completed Phase I clinical studies, is an acetylcholinesterase inhibitor. The pipelines for cancer (BIS-1602 - Breast, endometrial, ovarian cancers) and cardiology are based on Growth hormone Releasing Hormone (GHRH) - based on Nobel Laureate Biscayne co-founder, Dr. Andrew Schallys research.
Biscayne Pharma offers Health Blogs and Supplements Information.
Biscayne Pharma has 5 investors. Key investors include Supernus Pharmaceuticals, GF Securities, Quark Venture, Mesa Verde Venture Partners, and Florida Institute.
Yes. Biscayne Pharma was acquired by Supernus Pharmaceuticals in September 2018.